KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Progyny (PGNY) Return on Sales (2018 - 2025)

Historic Return on Sales for Progyny (PGNY) over the last 8 years, with Q3 2025 value amounting to 0.04%.

  • Progyny's Return on Sales rose 100.0% to 0.04% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.04%, marking a year-over-year decrease of 100.0%. This contributed to the annual value of 0.05% for FY2024, which is 100.0% down from last year.
  • Latest data reveals that Progyny reported Return on Sales of 0.04% as of Q3 2025, which was up 100.0% from 0.05% recorded in Q2 2025.
  • Progyny's Return on Sales' 5-year high stood at 0.15% during Q2 2021, with a 5-year trough of 0.02% in Q4 2022.
  • For the 5-year period, Progyny's Return on Sales averaged around 0.07%, with its median value being 0.05% (2023).
  • The largest annual percentage gain for Progyny's Return on Sales in the last 5 years was 1600bps (2021), contrasted with its biggest fall of -2700bps (2021).
  • Quarter analysis of 5 years shows Progyny's Return on Sales stood at 0.12% in 2021, then plummeted by -87bps to 0.02% in 2022, then skyrocketed by 214bps to 0.05% in 2023, then decreased by -29bps to 0.04% in 2024, then increased by 25bps to 0.04% in 2025.
  • Its Return on Sales stands at 0.04% for Q3 2025, versus 0.05% for Q2 2025 and 0.05% for Q1 2025.